A Day Up For CDAK

CDAK (CDAK:NASDAQ) shot up at $15.78, representing a gain of 34.6%. On Wed, Apr 21, 2021, CDAK:NASDAQ touched a New 2-Week Low of $11.72. The stock appeared on our News Catalysts scanner on Thu, Apr 22, 2021 at 07:32 AM in the 'BIOTECH' category. From Wed, Apr 07, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About CDAK (CDAK:NASDAQ)
Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics aimed at treating a broad range of diseases, including oncology,...
Top 10 Gainers:
- Ocugen, Inc. (OCGN:NASDAQ), 42.92%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 40.22%
- CDAK (CDAK:NASDAQ), 34.64%
- Teradata Corporation (TDC:NYSE), 26.63%
- AENZ (AENZ:NYSE), 25.64%
- UCL (UCL:NASDAQ), 23.07%
- XM (XM:NASDAQ), 22.71%
- CEL-SCI Corporation (CVM:NYSEMKT), 21.7%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 21.63%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 17.86%